Clinical referral to the NHS following multi-cancer early detection test results from the NHS-Galleri trial
To our knowledge, the NHS-Galleri trial has established the first model for the standardised clinical referral of asymptomatic individuals from a trial into NHS standard-of-care cancer pathways. We hope insights from our work could help accelerate screening trial conduct in the UK, and support MCED population screening programme implementation in future.
Authors
- Charles Swanton (ORCID: https://orcid.org/0000-0002-4299-3018)
- Raven Smith
- Lewis B. Holmes (ORCID: https://orcid.org/0000-0002-0259-4848)
- Lennard Y. W. Lee (ORCID: https://orcid.org/0000-0002-8993-8438)
- Saoirse Dolly (ORCID: https://orcid.org/0000-0002-3401-318X)
- Thomas Round (ORCID: https://orcid.org/0000-0003-4382-1629)
- Laura King (ORCID: https://orcid.org/0000-0002-7785-4712)
- Richard D Neal (ORCID: https://orcid.org/0000-0002-3544-2744)
- Sara Hiom
- Ian Lowenhoff
- Peter Johnson (ORCID: https://orcid.org/0000-0001-7780-8911)
Institutions
- Queen Mary University of London (GB)
- King's College London (GB)
- University of Exeter (GB)
- The Francis Crick Institute (GB)
- Cancer Research UK (GB)
- University of Oxford (GB)
- South London Healthcare NHS Trust (GB)
- London Cancer (GB)
- Grail (United States) (US)
- CRUK Lung Cancer Centre of Excellence (GB)
- University College London (GB)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fonc.2025.1511816
- Citations
- 6
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 5.62
Funders
- Queen Mary University of London
- Cancer Research UK